Genomic and Proteomic Biomarker Discovery in Neurological Disease

by Travis Dunckley, Andrew M. Siegel, RiLee H. Robeson
Published 2008-01-01

Genomic and Proteomic Biomarker Discovery in Neurological Disease

by RiLee H. Robeson, Andrew M. Siegel, Travis Dunckley
Published 2008-01-01

β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites.

by Danielle Frost, Bessie Meechoovet, Tong Wang, Stephen Gately, Marco Giorgetti, Irina Shcherbakova, Travis Dunckley
Published 2011-05-01

DNA Methylation and Expression Profiles of Whole Blood in Parkinson’s Disease

by Adrienne R. Henderson, Qi Wang, Bessie Meechoovet, Ashley L. Siniard, Marcus Naymik, Matthew De Both, Matthew J. Huentelman, Richard J. Caselli, Erika Driver-Dunckley, Travis Dunckley
Published 2021-04-01

SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening.

by Adrienne Henderson-Smith, Donald Chow, Bessie Meechoovet, Meraj Aziz, Sandra A Jacobson, Holly A Shill, Marwan N Sabbagh, John N Caviness, Charles H Adler, Erika D Driver-Dunckley, Thomas G Beach, Hongwei Yin, Travis Dunckley
Published 2013-01-01